Table 3 Overall population and subgroup analysis results for the IL-13-1112 polymorphism for different models
From: IL-13 -1112 polymorphism and periodontitis susceptibility: a meta-analysis
Model | Disease type | OR | 95% CI | P | I2 |
|---|---|---|---|---|---|
Periodontitis | 1.113 | 0.776–1.595 | 0.012 | 68.9% | |
C vsT | CP | 0.970 | 0.708–1.331 | 0.128 | 51.3% |
AgP | 1.445 | 0.489–4.271 | 0.012 | 84.3% | |
Periodontitis | 0.615 | 0.395–0.957 | 0.469 | 0.0% | |
CC vsTT | CP | 0.578 | 0.355–0.939 | 0.397 | 0.0% |
AgP | 0.840 | 0.285–2.475 | 0.211 | 36.1% | |
Periodontitis | 0.518 | 0.323–0.830 | 0.743 | 0.0% | |
CT vsTT | CP | 0.501 | 0.296–0.848 | 0.491 | 0.0% |
AgP | 0.593 | 0.203–1.735 | 0.486 | 0.0% | |
Periodontitis | 1.255 | 0.858–1.836 | 0.050 | 57.8% | |
CC vsCT+TT | CP | 1.032 | 0.800–1.331 | 0.355 | 3.4% |
AgP | 1.727 | 0.575–5.181 | 0.043 | 75.6% | |
Periodontitis | 1.739 | 1.130–2.676 | 0.554 | 0.0% | |
TT vsCT+CC | CP | 1.816 | 1.127–2.926 | 0.419 | 0.0% |
AgP | 1.427 | 0.520–3.921 | 0.270 | 17.9% |